COVID-19 outcomes for patients on immunosuppressive drugs on par with non- immunosuppressed patients

(Johns Hopkins University Bloomberg School of Public Health) People taking immunosuppressive drugs to prevent organ transplant rejection or to treat inflammatory or autoimmune diseases do not fare worse than others on average when they are hospitalized with COVID-19.